
==== Front
Clin Transl Med
Clin Transl Med
10.1002/(ISSN)2001-1326
CTM2
Clinical and Translational Medicine
2001-1326
John Wiley and Sons Inc. Hoboken

10.1002/ctm2.70033
CTM270033
Corrigendum
Corrigendum
Corrigendum to ‘Adipocyte‐specific FAK deletion promotes pancreatic β‐cell apoptosis via adipose inflammatory response to exacerbate diabetes mellitus’
24 9 2024
9 2024
24 9 2024
14 9 10.1002/ctm2.v14.9 e70033© 2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

10.1002/ctm2.1742 source-schema-version-number2.0
cover-dateSeptember 2024
details-of-publishers-convertorConverter:WILEY_ML3GV2_TO_JATSPMC version:6.4.8 mode:remove_FC converted:24.09.2024
==== Body
pmcIn this article, we have just realized the wrong usage of flow cytometry chart in the FAK siRNA group in Figure S7B of Supplementary Material.

The wrong Figure S7 is as follows.

The corrected Figure S7 is as follows.
